BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol. 2014;4:332-346. [PMID: 25755580 DOI: 10.1016/j.jceh.2014.10.002] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Fedele R, Salooja N, Martino M. Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation. Expert Opinion on Biological Therapy 2016;16:1361-72. [DOI: 10.1080/14712598.2016.1229773] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Bernichon E, Daguenet E, Molla C, Cornillon J, Lejeune C, Casteillo F, Guyotat D, Tavernier E. Sinusoidal obstruction syndrome/veno-occlusive disease complication in lymphoma patients treated with oxaliplatin-based regimen: A case series report. Current Research in Translational Medicine 2018;66:107-10. [DOI: 10.1016/j.retram.2018.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Kemmner S, Verbeek M, Heemann U. Renal dysfunction following bone marrow transplantation. J Nephrol 2017;30:201-9. [PMID: 27589851 DOI: 10.1007/s40620-016-0345-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
4 Anderson N, Borlak J. Hepatobiliary Events in Migraine Therapy with Herbs-The Case of Petadolex, A Petasites Hybridus Extract. J Clin Med 2019;8:E652. [PMID: 31083451 DOI: 10.3390/jcm8050652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
5 Baker DE, Demaris K. Defibrotide. Hosp Pharm 2016;51:847-54. [PMID: 27928191 DOI: 10.1310/hpj5110-847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Eusébio CP, Correia S, Silva F, Almeida M, Pedroso S, Martins S, Diais L, Queirós J, Pessegueiro H, Vizcaíno R, Henriques AC. Refractory ascites and graft dysfunction in early renal transplantation. J Bras Nefrol 2019;41:570-4. [PMID: 30897191 DOI: 10.1590/2175-8239-JBN-2018-0175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 van Mierlo KM, Zhao J, Kleijnen J, Rensen SS, Schaap FG, Dejong CH, Olde Damink SW. The influence of chemotherapy-associated sinusoidal dilatation on short-term outcome after partial hepatectomy for colorectal liver metastases: A systematic review with meta-analysis. Surgical Oncology 2016;25:298-307. [DOI: 10.1016/j.suronc.2016.05.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ruiz-manriquez J, Kauffman-ortega E, Gamboa-dominguez A, Ríos-valencia J, Ramirez-quesada W, Flores-garcía NC. Sinusoidal obstruction syndrome after liver transplantation: An interplay between thrombotic and immunological factors. A case report. Journal of Liver Transplantation 2021;2:100018. [DOI: 10.1016/j.liver.2021.100018] [Reference Citation Analysis]
9 Waespe N, Strebel S, Jurkovic Mlakar S, Krajinovic M, Kuehni CE, Nava T, Ansari M. Genetic Predictors for Sinusoidal Obstruction Syndrome-A Systematic Review. J Pers Med 2021;11:347. [PMID: 33925809 DOI: 10.3390/jpm11050347] [Reference Citation Analysis]
10 Lu Y, Wong KY, Tan C, Ma J, Feng B, Lin G. Establishment of a novel CYP3A4-transduced human hepatic sinusoidal endothelial cell model and its application in screening hepatotoxicity of pyrrolizidine alkaloids. J Environ Sci Health C Toxicol Carcinog 2020;38:169-85. [PMID: 32469285 DOI: 10.1080/26896583.2020.1769409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Fulgenzi A, Ferrero ME. Defibrotide in the treatment of hepatic veno-occlusive disease. Hepat Med 2016;8:105-13. [PMID: 27843363 DOI: 10.2147/HMER.S79243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Cen P, Ding J, Jin J. Hepatic sinusoidal obstruction syndrome caused by the ingestion of Gynura segetum in a patient with alcoholic cirrhosis: a case report. J Int Med Res 2021;49:300060520980649. [PMID: 33845617 DOI: 10.1177/0300060520980649] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Gracia-sancho J, Caparrós E, Fernández-iglesias A, Francés R. Role of liver sinusoidal endothelial cells in liver diseases. Nat Rev Gastroenterol Hepatol 2021;18:411-31. [DOI: 10.1038/s41575-020-00411-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
14 Zhang X, Thomas C, Schiano TD, Thung SN, Ward SC, Fiel MI. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy. Histopathology 2020;76:959-67. [PMID: 31994248 DOI: 10.1111/his.14083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Lin Y, Li Y, Hu X, Liu Z, Chen J, Lu Y, Liu J, Liao S, Zhang Y, Liang R, Lin Y, Li Q, Liang C, Yuan C, Liao X. The hepatoprotective role of reduced glutathione and its underlying mechanism in oxaliplatin-induced acute liver injury. Oncol Lett 2018;15:2266-72. [PMID: 29403564 DOI: 10.3892/ol.2017.7594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 Zhuge Y, Liu Y, Xie W, Zou X, Xu J, Wang J; Chinese Society of Gastroenterology Committee of Hepatobiliary Disease. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. J Gastroenterol Hepatol. 2019;34:634-642. [PMID: 30669184 DOI: 10.1111/jgh.14612] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
17 Zhou CZ, Wang RF, Lv WF, Fu YQ, Cheng DL, Zhu YJ, Hou CL, Ye XJ. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome. World J Gastroenterol 2020; 26(24): 3472-3483 [PMID: 32655270 DOI: 10.3748/wjg.v26.i24.3472] [Cited by in CrossRef: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yu YC, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, Ding Y, Duan ZP, Fu QC, Guo XY, Hu P, Hu XQ, Jia JD, Lai RT, Li DL, Liu YX, Lu LG, Ma SW, Ma X, Nan YM, Ren H, Shen T, Wang H, Wang JY, Wang TL, Wang XJ, Wei L, Xie Q, Xie W, Yang CQ, Yang DL, Yu YY, Zeng MD, Zhang L, Zhao XY, Zhuang H;  Drug-induced Liver Injury (DILI) Study Group;  Chinese Society of Hepatology (CSH);  Chinese Medical Association (CMA). CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11:221-241. [PMID: 28405790 DOI: 10.1007/s12072-017-9793-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 18.4] [Reference Citation Analysis]
19 Richardson PG, Grupp SA, Pagliuca A, Krishnan A, Ho VT, Corbacioglu S. Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure. Int J Hematol Oncol 2017;6:75-93. [PMID: 30302228 DOI: 10.2217/ijh-2017-0015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
20 Nicoară-Farcău O, Rusu I, Stefănescu H, Tanțău M, Badea RI, Procopeț B. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease. World J Gastroenterol 2020; 26(22): 3000-3011 [PMID: 32587444 DOI: 10.3748/wjg.v26.i22.3000] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Yang M, Ruan J, Gao H, Li N, Ma J, Xue J, Ye Y, Fu PP, Wang J, Lin G. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans. Arch Toxicol. 2017;91:3913-3925. [PMID: 28620673 DOI: 10.1007/s00204-017-2013-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
22 Massa López D, Thelen M, Stahl F, Thiel C, Linhorst A, Sylvester M, Hermanns-Borgmeyer I, Lüllmann-Rauch R, Eskild W, Saftig P, Damme M. The lysosomal transporter MFSD1 is essential for liver homeostasis and critically depends on its accessory subunit GLMP. Elife 2019;8:e50025. [PMID: 31661432 DOI: 10.7554/eLife.50025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
23 Braat MN, van Erpecum KJ, Zonnenberg BA, van den Bosch MA, Lam MG. Radioembolization-induced liver disease: a systematic review. European Journal of Gastroenterology & Hepatology 2017;29:144-52. [DOI: 10.1097/meg.0000000000000772] [Cited by in Crossref: 41] [Cited by in F6Publishing: 13] [Article Influence: 8.2] [Reference Citation Analysis]
24 Corbacioglu S, Topaloglu O, Aggarwal S. A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Clin Drug Investig 2022. [PMID: 35594010 DOI: 10.1007/s40261-022-01140-y] [Reference Citation Analysis]
25 Cayet S, Pasco J, Dujardin F, Besson M, Orain I, De Muret A, Miquelestorena-Standley E, Thiery J, Genet T, Le Bayon AG. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation. Eur J Radiol. 2017;94:180-190. [PMID: 28712693 DOI: 10.1016/j.ejrad.2017.06.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
26 Wells ML, Venkatesh SK. Congestive hepatopathy. Abdom Radiol (NY) 2018;43:2037-51. [PMID: 29147765 DOI: 10.1007/s00261-017-1387-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
27 Lange AP, Usmani AA, Wald C, Gordon FD. Sinusoidal Obstruction Syndrome in a Young Woman With Antiphospholipid Syndrome on Oral Contraceptives. Hepatology 2021;74:3539-41. [PMID: 34219254 DOI: 10.1002/hep.32041] [Reference Citation Analysis]
28 Otaka F, Ito Y, Goto T, Kojo K, Tanabe M, Hosono K, Majima M, Koizumi W, Amano H. Recovery of Liver Sinusoidal Endothelial Cells Following Monocrotaline-induced Liver Injury. In Vivo 2021;35:2577-87. [PMID: 34410945 DOI: 10.21873/invivo.12540] [Reference Citation Analysis]
29 Guo T, Li X, Yang X, Kong X, Liu H, Bai T, Xu K, Ye J, Song Y. Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function. Sci Rep. 2019;9:1231. [PMID: 30718698 DOI: 10.1038/s41598-018-37775-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
30 Yazaki T, Kawashima K, Ishimura N, Kataoka M, Fukunaga M, Hyakudomi R, Tajima Y, Moriyama I, Araki A, Kadota K, Shibagaki K, Tobita H, Ishihara S. Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites - Case Report. Intern Med 2022. [PMID: 35370236 DOI: 10.2169/internalmedicine.9266-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Corbacioglu S, Jabbour EJ, Mohty M. Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Biology of Blood and Marrow Transplantation 2019;25:1271-80. [DOI: 10.1016/j.bbmt.2019.02.018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
32 Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, Antin JH, Lehmann L, Miloslavsky M, Hume R, Hannah AL, Nejadnik B, Soiffer RJ. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation. Br J Haematol 2017;178:112-8. [PMID: 28444784 DOI: 10.1111/bjh.14727] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
33 Yang XQ, Ye J, Li X, Li Q, Song YH. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes. World J Gastroenterol 2019; 25(28): 3753-3763 [PMID: 31391770 DOI: 10.3748/wjg.v25.i28.3753] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
34 Takahashi M, Harada S, Suzuki H, Yamashita N, Orita H, Kato M, Kotoh K. Regorafenib could cause sinusoidal obstruction syndrome. J Gastrointest Oncol 2016;7:E41-4. [PMID: 27284487 DOI: 10.21037/jgo.2015.11.01] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Atilla E, Ataca Atilla P, Cengiz Seval G, Bektaş M, Demirer T. Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation. Turk J Gastroenterol 2019;30:122-31. [PMID: 30459131 DOI: 10.5152/tjg.2018.18156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Mori H, Saito YU, Iwahashi S, Ikemoto T, Imura S, Morine Y, Shimada M. Impact of Bevacizumab on Liver Damage After Massive Hepatectomy in Rats. In Vivo 2019;33:1469-76. [PMID: 31471394 DOI: 10.21873/invivo.11626] [Reference Citation Analysis]
37 Hildebrandt GC, Chao N. Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation. Br J Haematol 2020;190:508-19. [PMID: 32319084 DOI: 10.1111/bjh.16621] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
38 Ewing LE, McGill MR, Yee EU, Quick CM, Skinner CM, Kennon-McGill S, Clemens M, Vazquez JH, McCullough SS, Williams DK, Kutanzi KR, Walker LA, ElSohly MA, James LP, Gurley BJ, Koturbash I. Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration. Molecules 2019;24:E2256. [PMID: 31212965 DOI: 10.3390/molecules24122256] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
39 Lepelley M, Allouchery M, Long J, Boucherle D, Ranchoup Y, Marc’hadour FL, Villier C, Sturm N. Nodular Regenerative Hyperplasia Induced by Trastuzumab Emtansine: Role of Emtansine? Annals of Hepatology 2018;17:1067-71. [DOI: 10.5604/01.3001.0012.7207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Rayner P, Spruit JL, Chu R, Yankelevich M, Henry M, Ravindranath Y, Savaşan S. Role of Initiating Supportive Care Preceding Veno-occlusive Disease Diagnosis Following Allogeneic Hematopoietic Stem Cell Transplantation in Children. J Pediatr Hematol Oncol 2019;41:e395-401. [PMID: 30933024 DOI: 10.1097/MPH.0000000000001455] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Baiocchini A, Del Nonno F, Taibi C, Visco-Comandini U, D'Offizi G, Piacentini M, Falasca L. Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C. Sci Rep 2019;9:8760. [PMID: 31217430 DOI: 10.1038/s41598-019-45114-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
42 Kim H, Baek SE, Moon J, Roh YH, Lee N, Cho A. Increased hepatic FDG uptake on PET/CT in hepatic sinusoidal obstructive syndrome. Oncotarget 2016;7:69024-31. [PMID: 27602584 DOI: 10.18632/oncotarget.11816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
43 Takada S, Miyashita T, Yamamoto Y, Kanou S, Munesue S, Ohbatake Y, Nakanuma S, Okamoto K, Sakai S, Kinoshita J, Makino I, Nakamura K, Tajima H, Takamura H, Ninomiya I, Fushida S, Ohta T. Soluble Thrombomodulin Attenuates Endothelial Cell Damage in Hepatic Sinusoidal Obstruction Syndrome. In Vivo 2018;32:1409-17. [PMID: 30348695 DOI: 10.21873/invivo.11393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
44 Shang H, Bai T, Zhu S, Yang X, Liu C, Xu D, Zhuge Y, Song Y, Hou X. Prognostic factors for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: a multicenter study in China. Ann Transl Med 2021;9:11. [PMID: 33553304 DOI: 10.21037/atm-20-731] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Chauhan A, Faizi NA, Chen YJ, Jones LP, Garg N, Bhosale PR. Role of Ultrasound in Complications of Hematopoetic Stem Cell Transplantation. Ultrasound Q 2016;32:212-23. [PMID: 27556191 DOI: 10.1097/RUQ.0000000000000218] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Kanou S, Miyashita T, Yamamoto Y, Takada S, Nakura M, Okazaki M, Ohbatake Y, Nakanuma S, Makino I, Tajima H, Takamura H, Fushida S, Ohta T. Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice. In Vivo 2020;34:1037-45. [PMID: 32354890 DOI: 10.21873/invivo.11873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Liu F, Rong X, Guo H, Xu D, Liu C, Meng L, Yang X, Guo T, Kan X, Song Y. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. BMC Gastroenterol 2020;20:30. [PMID: 32019495 DOI: 10.1186/s12876-020-1180-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
48 Yeom MY, Kim YJ, Chung NG, Lee JW, Jang PS, Cho B, Kye CS, Jeong DC. Hepatic veno-occlusive disease may develop in secondary iron overloaded mice after allogeneic hematopoietic stem cell transplantation with total body irradiation. Blood Res 2015;50:140-6. [PMID: 26457280 DOI: 10.5045/br.2015.50.3.140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
49 Wang Y, Qiao D, Li Y, Xu F. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study. BMC Gastroenterol. 2018;18:156. [PMID: 30367628 DOI: 10.1186/s12876-018-0879-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
50 Erinjeri JP, Fine GC, Adema GJ, Ahmed M, Chapiro J, den Brok M, Duran R, Hunt SJ, Johnson DT, Ricke J, Sze DY, Toskich BB, Wood BJ, Woodrum D, Goldberg SN. Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper. Radiology 2019;292:25-34. [PMID: 31012818 DOI: 10.1148/radiol.2019182326] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
51 Cai X, Wu J, Gui R, Huang Q, Liu X, Qin Y, Wang J, Zeng Q, Jiang Q, Jiang H, Lu J, Wang J, Gao L, Zhang X, Zhang H, Feng J, Zhao X, Chang Y, Liu Y, Xu L, Liu K, Huang X, Zhang X. Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation. Ann Hematol 2019;98:1733-42. [DOI: 10.1007/s00277-019-03698-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
52 Rajesh S, Mukund A, Sureka B, Bansal K, Ronot M, Arora A. Non-cirrhotic portal hypertension: an imaging review. Abdom Radiol (NY) 2018;43:1991-2010. [PMID: 29564495 DOI: 10.1007/s00261-018-1570-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
53 Wang C, Wu X, Xie W, Ren X, Zhang W, Xu J. Quantitative Analysis of CT Images in Patients with Pyrrolizidine Alkaloid-Induced Sinusoidal Obstruction Syndrome. Sci Rep. 2019;9:2179. [PMID: 30778132 DOI: 10.1038/s41598-019-38669-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Xu T, Yang XQ, Song YH. Imaging manifestations of hepatic sinusoidal obstruction syndrome. Shijie Huaren Xiaohua Zazhi 2018; 26(36): 2083-2087 [DOI: 10.11569/wcjd.v26.i36.2083] [Reference Citation Analysis]
55 Aye JM, Xue W, Palmer JD, Walterhouse DO, Arnold MA, Heaton TE, Venkatramani R. Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group. Pediatr Blood Cancer 2021;68:e28914. [PMID: 33501771 DOI: 10.1002/pbc.28914] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Chen Y, Li L, Xiong F, Xie Y, Xiong A, Wang Z, Yang L. Rapid identification and determination of pyrrolizidine alkaloids in herbal and food samples via direct analysis in real-time mass spectrometry. Food Chem 2021;334:127472. [PMID: 32721831 DOI: 10.1016/j.foodchem.2020.127472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Mohty M, Battista ML, Blaise D, Calore E, Cesaro S, Maximova N, Perruccio K, Renard C, Wynn R, Zecca M, Labopin M, Hanvesakul R, Amber V, Ryan RJ, Lawson S, Ciceri F. A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study. Bone Marrow Transplant 2021. [PMID: 34059801 DOI: 10.1038/s41409-021-01265-2] [Reference Citation Analysis]
58 Ebbesen M, Weischendorff S, Kielsen K, Kammersgaard M, Juul A, Müller KG. Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant 2021;56:1021-30. [PMID: 33219341 DOI: 10.1038/s41409-020-01127-3] [Reference Citation Analysis]
59 Stein CA, Castanotto D. FDA-Approved Oligonucleotide Therapies in 2017. Mol Ther 2017;25:1069-75. [PMID: 28366767 DOI: 10.1016/j.ymthe.2017.03.023] [Cited by in Crossref: 366] [Cited by in F6Publishing: 346] [Article Influence: 73.2] [Reference Citation Analysis]
60 Kammersgaard MB, Kielsen K, Heilmann C, Ifversen M, Müller K. Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome. Bone Marrow Transplant 2019;54:1406-18. [PMID: 30683907 DOI: 10.1038/s41409-018-0426-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
61 von Salmuth V, van der Heiden Y, Bekkers I, van Runnard Heimel P, Spaanderman MA, Peeters LL, Koek GH. The role of hepatic sinusoidal obstruction in the pathogenesis of the hepatic involvement in HELLP syndrome: Exploring the literature. Pregnancy Hypertens 2020;19:37-43. [PMID: 31877439 DOI: 10.1016/j.preghy.2019.11.012] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 Al-Adham EK, Hassan AI, Shebl A, Hazem MM. Evaluation of the therapeutic effects of rice husk nanosilica combined with platelet-derived growth factor in hepatic veno-occlusive disease. Biochem Cell Biol 2018;96:682-94. [PMID: 29301090 DOI: 10.1139/bcb-2017-0248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
63 Richardson PG, Palomo M, Kernan NA, Hildebrandt GC, Chao N, Carreras E. The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae. Bone Marrow Transplant 2021. [PMID: 34584241 DOI: 10.1038/s41409-021-01383-x] [Reference Citation Analysis]
64 Sanz-garcía C, Fernández-iglesias A, Gracia-sancho J, Arráez-aybar LA, Nevzorova YA, Cubero FJ. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021;1:3-26. [DOI: 10.3390/livers1010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
65 Liu F, Cao X, Ye J, Pan X, Kan X, Song Y. Oxaliplatin-induced hepatic sinusoidal obstruction syndrome in a patient with gastric cancer: A case report. Mol Clin Oncol. 2018;8:453-456. [PMID: 29468059 DOI: 10.3892/mco.2017.1540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
66 Themanns M, Koban F, Bergmayr C, Chrzan A, Strohmaier W, Haybaeck J, Freissmuth M, Zebedin-Brandl E. Treprostinil reduces endothelial damage in murine sinusoidal obstruction syndrome. J Mol Med (Berl) 2019;97:201-13. [PMID: 30535954 DOI: 10.1007/s00109-018-1726-6] [Reference Citation Analysis]
67 Hassan C, Correal F, Vézina G, Yelle L, Adam JP. Safety of trastuzumab after trastuzumab emtansine-induced nodular regenerative hyperplasia: A case report. J Oncol Pharm Pract 2020;26:1780-4. [PMID: 32192389 DOI: 10.1177/1078155220910252] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Furlan A, Minervini MI, Borhani AA, Dioguardi Burgio M, Tublin ME, Brancatelli G. Hepatic Sinusoidal Dilatation: A Review of Causes With Imaging-Pathologic Correlation. Seminars in Ultrasound, CT and MRI 2016;37:525-32. [DOI: 10.1053/j.sult.2016.08.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
69 Brancatelli G, Furlan A, Calandra A, Dioguardi Burgio M. Hepatic sinusoidal dilatation. Abdom Radiol (NY) 2018;43:2011-22. [PMID: 29392360 DOI: 10.1007/s00261-018-1465-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
70 Shigefuku R, Watanabe T, Mizukami T, Matsunaga K, Hattori N, Ehira T, Suzuki T, Nakano H, Sato Y, Matsuo Y, Nakahara K, Ikeda H, Matsumoto N, Tsuda T, Katayama M, Koizumi S, Okuse C, Suzuki M, Otsubo T, Nakajima TE, Yasuda H, Itoh F. Esophagogastric varices were diagnosed in a non-cirrhotic liver case during long-term follow-up after oxaliplatin-based chemotherapy. Clin J Gastroenterol 2018;11:487-92. [PMID: 29948819 DOI: 10.1007/s12328-018-0873-1] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
71 Ballotin VR, Bigarella LG, Brandão ABM, Balbinot RA, Balbinot SS, Soldera J. Herb-induced liver injury: Systematic review and meta-analysis. World J Clin Cases 2021; 9(20): 5490-5513 [PMID: 34307603 DOI: 10.12998/wjcc.v9.i20.5490] [Reference Citation Analysis]
72 Philips CA, Augustine P, Paramaguru R, Ahamed R, Padsalgi G. Ayurveda Herbal Medicine-induced Liver Cirrhosis. Cureus 2019;11:e4122. [PMID: 31037236 DOI: 10.7759/cureus.4122] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Bedossa P, Hytiroglou P, Yeh MM. Vascular Disorders. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 636-72. [DOI: 10.1016/b978-0-7020-6697-9.00011-x] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
74 Richardson PG, Krishnan A, Giralt S, Soiffer RJ. Defibrotide for the treatment of severe hepatic veno-occlusive disease/sinusoidal obstruction syndrome: evidence for clinical benefit. Expert Opinion on Orphan Drugs 2015;3:1491-501. [DOI: 10.1517/21678707.2015.1114455] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
75 Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, Dignan F, Gibson B, Guengoer T, Gruhn B, Lankester A, Locatelli F, Pagliuca A, Peters C, Richardson PG, Schulz AS, Sedlacek P, Stein J, Sykora KW, Toporski J, Trigoso E, Vetteranta K, Wachowiak J, Wallhult E, Wynn R, Yaniv I, Yesilipek A, Mohty M, Bader P. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant 2018;53:138-45. [PMID: 28759025 DOI: 10.1038/bmt.2017.161] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 21.0] [Reference Citation Analysis]
76 Stein C, Castanotto D, Krishnan A, Nikolaenko L. Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs. Mol Ther Nucleic Acids 2016;5:e346. [PMID: 28131276 DOI: 10.1038/mtna.2016.42] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
77 Kohnken R, Falahatpisheh H, Janardhan KS, Guffroy M. Anatomic and Clinical Pathology Characterization of Drug-Induced Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease) in Cynomolgus Macaques. Toxicol Pathol 2021;:1926233211037932. [PMID: 34414838 DOI: 10.1177/01926233211037932] [Reference Citation Analysis]
78 Tu H, Li M, Chen Z, Zhao J, Wang H, Qian J, Wei C, Yang Y, Zhu Y, Zuo L. Plateletcrit for predicting prognosis in patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloid. J Clin Lab Anal 2022;:e24240. [PMID: 35034375 DOI: 10.1002/jcla.24240] [Reference Citation Analysis]
79 De La Pinta Alonso C. Radiation-induced liver disease in the era of SBRT: a review. Expert Rev Gastroenterol Hepatol 2020;14:1195-201. [PMID: 32886888 DOI: 10.1080/17474124.2020.1814744] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Fuentes-Lacouture MC, Barrera-Garavito EC, Gomez A, Mantilla W. Non-Cirrhotic Portal Hypertension in a Patient With Colonic Carcinoma Treated With Oxaliplatin. J Med Cases 2021;12:99-101. [PMID: 34434437 DOI: 10.14740/jmc3630] [Reference Citation Analysis]
81 Jafari A, Matthaei H, Wehner S, Tonguc T, Kalff JC, Manekeller S. Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production. Oncotarget 2018;9:21797-810. [PMID: 29774103 DOI: 10.18632/oncotarget.25021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Liu K, Chen X, Ren Y, Liu C, Zhang J, Wang Z, Li Y, Zhang Y. 3,3',5-triiodo-l-thyronine inhibits drug-induced liver injury through activation of PPARα as revealed by network pharmacology and biological experimental verification. Toxicol Appl Pharmacol 2022;448:116098. [PMID: 35662663 DOI: 10.1016/j.taap.2022.116098] [Reference Citation Analysis]
83 Günther S, Perros F, Rautou P, Girerd B, Ghigna M, Cazals-hatem D, Lau EM, Dorfmüller P, Sitbon O, Valla DC, Humbert M, Montani D. Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease. The American Journal of Pathology 2019;189:1159-75. [DOI: 10.1016/j.ajpath.2019.02.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
84 Luo S, Chu J, Huang H, Yao K. Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids. Biomed Res Int 2018;2018:9804582. [PMID: 30009181 DOI: 10.1155/2018/9804582] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Kernan NA, Richardson PG, Smith AR, Triplett BM, Antin JH, Lehmann L, Messinger Y, Liang W, Hume R, Tappe W, Soiffer RJ, Grupp SA. Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program. Pediatr Blood Cancer 2018;65:e27269. [PMID: 29873895 DOI: 10.1002/pbc.27269] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
86 Sabatino D, Henneman A, Ahmad S, Jou E, Goldberg B. Evaluation of the efficacy of ursodiol for prevention of hepatotoxicity in patients receiving gemtuzumab ozogamicin and inotuzumab ozogamicin. J Oncol Pharm Pract 2022;:10781552221084000. [PMID: 35293248 DOI: 10.1177/10781552221084000] [Reference Citation Analysis]
87 Damm R, Pech M, Cavalli P, Haag F, Gylstorff S, Omari J, Thormann M, Seidensticker R, Ricke J, Seidensticker M, Relja B. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases. J Cancer Res Clin Oncol 2022. [PMID: 35596772 DOI: 10.1007/s00432-022-04041-x] [Reference Citation Analysis]
88 Hematopoietic Stem Cell Application Group, Chinese Society of Hematology, Chinese Medical Association. [Chinese consensus on the diagnosis and management of transplant-associated thrombotic microangiopathy (2021)]. Zhonghua Xue Ye Xue Za Zhi 2021;42:177-84. [PMID: 33910301 DOI: 10.3760/cma.j.issn.0253-2727.2021.03.001] [Reference Citation Analysis]
89 Chen X, Ma J, He Y, Xue J, Song Z, Xu Q, Lin G. Characterization of liver injury induced by a pyrrolizidine alkaloid in rats. Phytomedicine 2021;89:153595. [PMID: 34153877 DOI: 10.1016/j.phymed.2021.153595] [Reference Citation Analysis]
90 Xue DQ, Yang L. Development of Focal Nodular Hyperplasia after Cyclophosphamide-Based Chemotherapy in a Patient with Breast Cancer. Case Reports Hepatol 2018;2018:5409316. [PMID: 30425864 DOI: 10.1155/2018/5409316] [Reference Citation Analysis]
91 Szmit Z, Gorczynska E, Król A, Ussowicz M, Mielcarek-Siedziuk M, Olejnik I, Panasiuk A, Kałwak K. Introduction of new pediatric EBMT criteria for VOD diagnosis: is it time-saving or money-wasting? : Prospective evaluation of pediatric EBMT criteria for VOD. Bone Marrow Transplant 2020;55:2138-46. [PMID: 32398785 DOI: 10.1038/s41409-020-0918-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
92 Sakumura M, Tajiri K, Miwa S, Nagata K, Kawai K, Miyazono T, Arita K, Wada A, Murakami J, Sugiyama T. Hepatic Sinusoidal Obstruction Syndrome Induced by Non-transplant Chemotherapy for Non-Hodgkin Lymphoma. Intern Med 2017;56:395-400. [PMID: 28202860 DOI: 10.2169/internalmedicine.56.7669] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
93 Liu Y, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG. Is sinusoidal obstructive syndrome a recurrent disease after liver transplantation? A case report . World J Clin Cases 2021; 9(2): 489-495 [PMID: 33521120 DOI: 10.12998/wjcc.v9.i2.489] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
94 Park SH, Lee SS, Sung JY, Na K, Kim HJ, Kim SY, Park BJ, Byun JH. Noninvasive assessment of hepatic sinusoidal obstructive syndrome using acoustic radiation force impulse elastography imaging: A proof-of-concept study in rat models. Eur Radiol. 2018;28:2096-2106. [PMID: 29218616 DOI: 10.1007/s00330-017-5179-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
95 Assarzadegan N, Anders RA, Oshima K. Hepatic vascular diseases. Diagnostic Histopathology 2017;23:553-8. [DOI: 10.1016/j.mpdhp.2017.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
96 Calistri L, Rastrelli V, Nardi C, Maraghelli D, Vidali S, Pietragalla M, Colagrande S. Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis. World J Gastroenterol 2021; 27(46): 7866-7893 [DOI: 10.3748/wjg.v27.i46.7866] [Reference Citation Analysis]
97 Poisson J, Lemoinne S, Boulanger C, Durand F, Moreau R, Valla D, Rautou PE. Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J Hepatol. 2017;66:212-227. [PMID: 27423426 DOI: 10.1016/j.jhep.2016.07.009] [Cited by in Crossref: 324] [Cited by in F6Publishing: 307] [Article Influence: 54.0] [Reference Citation Analysis]
98 Barcelos STA, Dall'Oglio VM, de Araújo A, Cerski CTS, Álvares-da-Silva MR. Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case report. Ann Hepatol 2021;20:100138. [PMID: 31606353 DOI: 10.1016/j.aohep.2019.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
99 Gangi A, Lu SC. Chemotherapy-associated liver injury in colorectal cancer. Therap Adv Gastroenterol 2020;13:1756284820924194. [PMID: 32547639 DOI: 10.1177/1756284820924194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Singh VK, Seed TM. Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems. Expert Opin Pharmacother 2020;21:317-37. [PMID: 31928256 DOI: 10.1080/14656566.2019.1702968] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
101 De Clercq K, Xie F, De Wever O, Descamps B, Hoorens A, Vermeulen A, Ceelen W, Vervaet C. Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer. Sci Rep 2019;9:14881. [PMID: 31619730 DOI: 10.1038/s41598-019-51419-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
102 Bakshi N, Rastogi A, Pamecha V, Bihari C. Sinusoidal dilatation and congestion in post-transplant liver biopsies from patients presenting with transaminitis. J Clin Pathol 2020:jclinpath-2020-206870. [PMID: 32839160 DOI: 10.1136/jclinpath-2020-206870] [Reference Citation Analysis]
103 Ngo D, Jia JB, Green CS, Gulati AT, Lall C. Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective. Insights Imaging 2015;6:665-77. [PMID: 26443452 DOI: 10.1007/s13244-015-0436-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
104 Godwin CD, McDonald GB, Walter RB. Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia. Blood 2017;129:2330-2. [PMID: 28153826 DOI: 10.1182/blood-2017-01-762419] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
105 Ferraioli G, Barr RG. Ultrasound liver elastography beyond liver fibrosis assessment. World J Gastroenterol 2020; 26(24): 3413-3420 [PMID: 32655265 DOI: 10.3748/wjg.v26.i24.3413] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
106 Lo EC, N. Rucker A, Federle MP. Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Imaging for Diagnosis, Tumor Response to Treatment and Liver Response to Radiation. Seminars in Radiation Oncology 2018;28:267-76. [DOI: 10.1016/j.semradonc.2018.06.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
107 Roy Moulik N, Johnson I, Van Bruggen L, Petterson T, Mycroft J, Vaidya SJ. Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high-dose chemotherapy: A single-center experience from the Royal Marsden Hospital, UK. Pediatr Blood Cancer 2020;67:e28677. [PMID: 32865880 DOI: 10.1002/pbc.28677] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Zhu C, Ren X, Liu D, Zhang C. Oxaliplatin-induced hepatic sinusoidal obstruction syndrome. Toxicology 2021;460:152882. [PMID: 34352347 DOI: 10.1016/j.tox.2021.152882] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Freeman AF, Yazigi N, Shah NN, Kleiner DE, Parta M, Atkinson P, Heller T, Holland SM, Kaufman SS, Khan KM, Hickstein DD. Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency. Transplantation 2019;103:2144-9. [PMID: 30720689 DOI: 10.1097/TP.0000000000002649] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
110 Shah M, Rajha E, Dinardo C, Muckey E, Wierda WG, Yeung SJ. Adverse Events of Novel Therapies for Hematologic Malignancies: What Emergency Physicians Should Know. Annals of Emergency Medicine 2020;75:264-86. [DOI: 10.1016/j.annemergmed.2019.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
111 Zhang W, Liu L, Zhang M, Zhang F, Peng C, Zhang B, Chen J, Li L, He J, Xiao J, Feng Y, Wang X, Xiong A, Yang L, Zou X, Yu Y, Zhuge Y. Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome. J Clin Transl Hepatol 2021;9:345-52. [PMID: 34221920 DOI: 10.14218/JCTH.2020.00124] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Cordes S, Mokhtari Z, Bartosova M, Mertlitz S, Riesner K, Shi Y, Mengwasser J, Kalupa M, McGeary A, Schleifenbaum J, Schrezenmeier J, Bullinger L, Diaz-Ricart M, Palomo M, Carrreras E, Beutel G, Schmitt CP, Beilhack A, Penack O. Endothelial damage and dysfunction in acute graft-versus-host disease. Haematologica 2021;106:2147-60. [PMID: 32675225 DOI: 10.3324/haematol.2020.253716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
113 Khan F, Armstrong MJ, Mehrzad H, Chen F, Neil D, Brown R, Cain O, Tripathi D. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther. 2019;49:840-863. [PMID: 30828850 DOI: 10.1111/apt.15149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
114 Nickel NP, Galura GM, Zuckerman MJ, Hakim MN, Alkhateeb H, Mukherjee D, Austin ED, Heresi GD. Liver abnormalities in pulmonary arterial hypertension. Pulm Circ 2021;11:20458940211054304. [PMID: 34707859 DOI: 10.1177/20458940211054304] [Reference Citation Analysis]
115 Jain R, Gupta K, Bhatia A, Bansal A, Bansal D. Hepatic Sinusoidal-obstruction Syndrome and Busulfan-induced Lung Injury in a Post-autologous Stem Cell Transplant Recipient. Indian Pediatr 2017;54:765-70. [PMID: 28984258 DOI: 10.1007/s13312-017-1172-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
116 Sun Z, Kang J, Zhang Y. Hepatic veno-occlusive disease related to Gynura segetum: A case report. Medicine (Baltimore) 2018;97:e0552. [PMID: 29703039 DOI: 10.1097/MD.0000000000010552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
117 Allegra A, Tonacci A, Musolino C, Pioggia G, Gangemi S. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia. Front Immunol 2021;12:738915. [PMID: 34759921 DOI: 10.3389/fimmu.2021.738915] [Reference Citation Analysis]
118 Yu J, Gao Y, Chen L, Wu D, Shen Q, Zhao Z, Liu W, Yang H, Zhang Q, Wang X, Hu P, Zheng Z, Wang X, Liu H, Xu Z, Yan Z, Wu Y, Jin M, Zhang Q, Liu X, Zhu K, Shou C. Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer: A Randomized Clinical Trial. JAMA Netw Open 2022;5:e220426. [PMID: 35226081 DOI: 10.1001/jamanetworkopen.2022.0426] [Reference Citation Analysis]
119 Zhang L, Li Q, Makamure J, Zhao D, Liu Z, Zheng C, Liang B. Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. BMC Gastroenterol 2021;21:26. [PMID: 33423668 DOI: 10.1186/s12876-021-01599-7] [Reference Citation Analysis]
120 Xia Y, Qin H, Yang J. Hepatic veno-occlusive disease development in the hematopoietic stem cell transplantation patients: incidence and associated risk factors, a meta-analysis. Eur J Gastroenterol Hepatol 2021;33:872-84. [PMID: 32639417 DOI: 10.1097/MEG.0000000000001802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Rathi S, Dhiman RK. Hepatobiliary quiz (answers)-13 (2015). J Clin Exp Hepatol 2015;5:100-4. [PMID: 25941440 DOI: 10.1016/j.jceh.2015.03.002] [Reference Citation Analysis]
122 Richardson PG, Carreras E, Iacobelli M, Nejadnik B. The use of defibrotide in blood and marrow transplantation. Blood Adv 2018;2:1495-509. [PMID: 29945939 DOI: 10.1182/bloodadvances.2017008375] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
123 Hong EK, Joo I, Park J, Lee K. Assessment of hepatic sinusoidal obstruction syndrome with intravoxel incoherent motion diffusion-weighted imaging: An experimental study in a rat model. J MagnReson Imaging. 2020;51:81-89. [PMID: 31094055 DOI: 10.1002/jmri.26790] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
124 Huang Z, Sheng Y, Chen M, Hao Z, Hu F, Ji L. Liquiritigenin and liquiritin alleviated MCT-induced HSOS by activating Nrf2 antioxidative defense system. Toxicology and Applied Pharmacology 2018;355:18-27. [DOI: 10.1016/j.taap.2018.06.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
125 Stevenson HL, Prats MM, Sasatomi E. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis. BMC Cancer. 2017;17:35. [PMID: 28061766 DOI: 10.1186/s12885-016-2998-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
126 Xu J, Wang W, Yang X, Xiong A, Yang L, Wang Z. Pyrrolizidine alkaloids: An update on their metabolism and hepatotoxicity mechanism. Liver Research 2019;3:176-84. [DOI: 10.1016/j.livres.2019.11.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
127 Mulder PPJ, de Witte SL, Stoopen GM, van der Meulen J, van Wikselaar PG, Gruys E, Groot MJ, Hoogenboom RLAP. Transfer of pyrrolizidine alkaloids from various herbs to eggs and meat in laying hens. Food Additives & Contaminants: Part A 2016;33:1826-39. [DOI: 10.1080/19440049.2016.1241430] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
128 Martins J, Alexandrino H, Oliveira R, Cipriano M, Falcão D, Ferreira L, Martins R, Serôdio M, Martins M, Tralhão J, Prado e Castro L, Castro e Sousa F. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM – Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor. European Journal of Surgical Oncology (EJSO) 2016;42:713-21. [DOI: 10.1016/j.ejso.2016.02.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]